Opportunities in metabolic engineering to facilitate scalable alkaloid production
Numerous drugs and drug precursors in the current pharmacopoeia originate from plant sources. The limited yield of some bioactive compounds in plant tissues, however, presents a significant challenge for large-scale drug development. Metabolic engineering has facilitated the development of plant cel...
Main Authors: | Leonard, Effendi, Runguphan, Weerawat, O'Connor, Sarah Ellen, Prather, Kristala L. Jones |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2012
|
Online Access: | http://hdl.handle.net/1721.1/68707 https://orcid.org/0000-0003-0437-3157 |
Similar Items
-
Silencing of tryptamine biosynthesis for production of nonnatural alkaloids in plant culture
by: O'Connor, Sarah Ellen, et al.
Published: (2010) -
Reprogramming alkaloid biosynthesis in Catharanthus roseus : synthetic biology in plants
by: Runguphan, Weerawat
Published: (2011) -
Redesign of a Dioxygenase in Morphine Biosynthesis
by: Runguphan, Weerawat, et al.
Published: (2014) -
Synthetic biology devices as tools for metabolic engineering
by: Shiue, Eric, et al.
Published: (2019) -
Controlled biosynthesis of odd-chain fuels and chemicals via engineered modular metabolic pathways
by: Tseng, Hsien-Chung, et al.
Published: (2013)